Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Some thoughts on experimental screening.

S K Carter

    Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]
    |January 1, 1975
    PubMed
    Summary
    This summary is machine-generated.

    Developing effective anticancer drugs requires close collaboration between researchers and clinicians. This involves screening drug analogues, optimizing combination therapies, and integrating treatments for better cancer care.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Tyrosine kinase inhibitors and signal transduction modulators: Rationale and current status as chemopreventive agents for prostate cancer.

    Urology·2001
    Same author

    Clinical strategy for the development of angiogenesis inhibitors.

    The oncologist·2000
    Same author

    Clinical research and drug development of antivirals in HIV: an industry perspective.

    Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association·1995
    Same author

    Cancer chemotherapy 1973-present: a personal perspective.

    Journal of cancer research and clinical oncology·1995
    Same author

    Phase III trial of irradiation plus chemotherapy for patients with hepatic metastases and hepatoma: experience of the Northern California Oncology Group.

    NCI monographs : a publication of the National Cancer Institute·1988
    Same author

    Improving the therapeutic index of systemic therapy with special emphasis on cisplatin and carboplatin.

    Cancer treatment reviews·1987
    Same journal

    Characterization of a major natural killer activity in rat lungs.

    Biomedicine / [publiee pour l'A.A.I.C.I.G.]·1981
    Same journal

    Decreased phagocytosis and antibody-dependent cellular cytotoxicity (ADCC) in type-1 diabetes.

    Biomedicine / [publiee pour l'A.A.I.C.I.G.]·1981
    Same journal

    [Alveolar macrophages in asthmatic patients: study of their phagocytic function].

    Biomedicine / [publiee pour l'A.A.I.C.I.G.]·1981
    Same journal

    Effect of salbutamol, a putative cerebral beta agonist on sleep stages and interictal epileptic discharges.

    Biomedicine / [publiee pour l'A.A.I.C.I.G.]·1981
    Same journal

    Ganglioside content and pattern in tumor tissue of human neuroblastomas.

    Biomedicine / [publiee pour l'A.A.I.C.I.G.]·1981
    Same journal

    Protective effect of levamisole on carbon tetrachloride-induced lipid peroxidation and hepatotoxicity.

    Biomedicine / [publiee pour l'A.A.I.C.I.G.]·1981
    See all related articles

    Area of Science:

    • Oncology
    • Pharmacology
    • Drug Development

    Background:

    • Experimental screening is crucial for identifying novel anticancer drugs.
    • Translating preclinical findings into effective human therapies presents significant challenges.

    Purpose of the Study:

    • To emphasize the necessity of collaboration between experimentalists and clinicians in anticancer drug development.
    • To outline key considerations for advancing drug candidates from laboratory research to human clinical trials.

    Main Methods:

    • Screening of known active drug analogues using chemical synthesis and experimental tumor models.
    • Evaluating experimental systems for rational design of combination drug regimens.
    • Assessing variables such as dose ratio, schedule, and sequence of administration.

    Related Experiment Videos

    Main Results:

    • Close cooperation is essential for successful drug development and clinical translation.
    • Specific experimental approaches are needed to guide the design of combination therapies.
    • Integrating drug screening with other modalities like surgery and immunotherapy is complex.

    Conclusions:

    • Enhanced collaboration between experimental and clinical studies is vital for overcoming the complexities of designing improved cancer treatments.
    • Rational design of combination therapies requires robust experimental data.
    • A multidisciplinary approach is necessary for comprehensive cancer treatment strategies.